Synopsis Hemostasis or haemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of&nb.....
SynopsisHepatitis C drugs are medications used to treat hepatitis C virus (HCV) infection. Over the years, significant advancements have been made in HCV treatment, leading to the development of direct-acting antivirals (DAAs). These drugs target specific steps in the.....
SynopsisHepatitis C drugs are medications used to treat hepatitis C virus (HCV) infection. Over the years, significant advancements have been made in HCV treatment, leading to the development of direct-acting antivirals (DAAs). These drugs target specific steps in the.....
SynopsisA-hydrocort (hydrocortisone sodium succinate) is a corticosteroid used to treat arthritis, endocrine disorders, lupus, allergies and asthma, and other conditions. It works by decreasing inflammation in different parts of the body such as around tumors or nerve.....
SynopsisA-Methapred (methylprednisolone sodium succinate for injection, USP) sterile powder contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, occurs as a white, or nearly white, odorless hygroscopic, amorp.....
SynopsisELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The global Eloctate market was valued at US$ 1245 million in 2023 and is anticipated to reach US$ 996.1 million .....
SynopsisELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The global Acquired hemophilia A Drugs market was valued at US$ 1245 million in 2023 and is anticipated to reach.....
SynopsisELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer. The global Acquired hemophilia A Treatment market was valued at US$ 1245 million in 2023 and is anticipated to r.....
SynopsisAldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. The global Aldesleukin market was valued at US$ 158.6 million in 2023 and is anticipa.....
SynopsisProleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. The global Proleukin market was valued at US$ 158.6 million in 2023 and is anticipated .....
